RWCS
A

RWCS 2021 Highlights on Biologics/tsDMARDs: What Are the Commonly Considered Potential Safety Issues? What Is the Lymphoma Incidence in RA & Risk for VTE?

By RWCS FEATURING Arthur Kavanaugh, John J. Cush
By RWCS FEATURING Arthur Kavanaugh, John J. Cush
0 views
April 9, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

39:42
Boehringer Ingelheim

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

Recommended

AUTOPLAY
19:49
Rush University Medical Center

COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Feat. S. Jain
18:41
CHEST 2022 Coverage

Role of Anticoagulants and Antiplatelet Agents for Patients With COV…

Feat. V. Balasubramanian
21:20
Cleveland Clinic Rheumatology

How do I Recognize and Treat the VEXAS Syndrome?

Feat. P. Grayson
22:08
RheumNow

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

Feat. J. Cush
26:31
Cleveland Clinic Rheumatology

Clinical Approach to Diagnosis and Treatment of Cytokine Storm in Rh…

Feat. R. Q. Cron
25:25
Keck School of Medicine of USC

Update on the New ANA Classification System

Feat. E. Taylor-Albert
28:32
West Virginia State Rheumatology Society

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

Feat. J. Bustamante
28:59
Scripps Health

Management of Simultaneous Venous and Arterial Thromboembolic Disease

Feat. J. May
25:16
Cleveland Clinic Rheumatology

Integrative Health Approaches for Optimum Immune Health

Feat. C. Wang
27:14
2024 Clinical Case Studies

Clinical Case Review: Cutaneous T Cell Lymphoma in the Patch Test Cl…

Feat. J. Murase
13:16
ASH 2022 Conference Coverage

Experts Discuss Key Updates in CLL

Feat. S. O'Brien, C. Coombs
10:18
RheumNow

Points to Consider When Managing Inflammatory Arthritis with Cancer

Feat. J. Cush
28:10
Indy Hematology Review

Current Review of Benign Hematology and Coagulopathy

Feat. C. Kessler
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
10:35
Alan Skarbnik

Learnings From the ELEVATE-TN Phase 3 Trial: Acalabrutinib+/-Obinutu…

13:36
Vanderbilt University Medical Center (VUMC)

Venous Thromboembolism Prophylaxis in Newly Diagnosed MM

Feat. M. Baljevic
10:27
Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

56:29
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Update in Thromboembolism

Feat. D. Garcia
51:20
Jerry Spivak

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

04:14
ecancer

ALPINE: A Randomized Phase 3 Study of Zanubrutinib vs. Ibrutinib for…

Feat. J. Brown